Emerging research suggest Retatrutide , a dual stimulator targeting both the gut-brain axis and another hormone, could offer a significant development for obesity management . Initial patient tests have indicated considerable losses in abdominal tissue, possibly outperforming current body composition treatments. Nevertheless , additional study is r